In this study, we analyzed and verified the expression of PRR11 in BLCA using GEPIA, Oncomine, TCGA, and other databases before calculating its significance in the clinical prognosis of patients using various statistical methods. This evidence concerns the gene PRR11 and bladder transitional cell carcinoma.